The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Response rate with cetuximab used less than 3 months after immunotherapy (IO) for recurrent/metastatic head and neck squamous cell carcinomas (R/M HNSCC) compared to larger delay.
 
Yannick Carulla
No Relationships to Disclose
 
Eve-Marie Neidhardt
Consulting or Advisory Role - Pierre Fabre (Inst)
Travel, Accommodations, Expenses - Le cancer.fr; Pierre Fabre
 
Andy Karabajakian
No Relationships to Disclose
 
Thibault Gauduchon
No Relationships to Disclose
 
Hemerson Guevara
No Relationships to Disclose
 
pierre Eric Roux
No Relationships to Disclose
 
Philippe Zrounba
No Relationships to Disclose
 
Fabien Podeur
No Relationships to Disclose
 
Marc Poupart
No Relationships to Disclose
 
Aude Excoffier
No Relationships to Disclose
 
Jerome Fayette
Honoraria - Bristol-Myers Squibb; Hookipa Pharma; Merck Serono; Merck Sharp & Dohme; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Elevar Therapeutics; Hookipa Pharma; ITeos Therapeutics; Merck Serono; Merck Sharp & Dohme; Seagen
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme